格隆汇11月13日丨智云健康(09955.HK)宣布，公司近日与京东健康股份有限公司("京东健康"，一家于香 港联交所上市的公司，股份代号：6618.HK)订立服务合作协议，旨在拓宽莉芙敏片®及其他P2M管线产 品的线上销售与服务渠道，为患者提供更便捷的购药体验与专业的全周期健康管理服务。 作为中国最大的医药电商平台，京东健康具有庞大的用户基础及广泛平台资源，而作为中国领先的慢病 管理平台，公司拥有独特的产品管线及医患管理专业能力。此次双方的合作代表强强联合，将能高效推 广优质且具成本效益的药品。 ...

Core Viewpoint - The collaboration between Zhiyun Health and JD Health aims to enhance online sales and service channels for Livermore tablets and other P2M pipeline products, providing patients with a more convenient purchasing experience and comprehensive health management services [1] Group 1: Partnership Details - Zhiyun Health has entered into a service cooperation agreement with JD Health, a major player in the Chinese pharmaceutical e-commerce market [1] - The partnership is expected to leverage JD Health's extensive user base and platform resources to promote high-quality and cost-effective medications [1] Group 2: Strategic Implications - This collaboration represents a strong alliance between two leading companies in their respective fields, enhancing the potential for effective promotion of health management solutions [1] - The partnership will facilitate better patient access to medications and health management services, aligning with the growing trend of digital health solutions in China [1]